Phoenix Nest is a collaborative company focused on treating Sanfilippo Syndrome (Mucopolysaccharidosis (MPS) IIIB, IIIC and IIID). Our goal is to bring these treatments to market as quickly as possible. We are working with the leading academics and have engaged in a strategy of licensing key technologies to facilitate this goal.
View Top Employees from Phoenix Nest Inc.Website | http://www.phoenixnestbiotech.com |
Revenue | $8 million |
Employees | 7 (4 on RocketReach) |
Founded | 2012 |
Address | 254 36th St Ste B631, Brooklyn, New York 11232, US |
Phone | (917) 909-0553 |
Fax | (917) 591-0607 |
Industry | Biotechnology Research, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering |
Competitors | Innocutis Medical, LLC, The BioScience Center |
SIC | SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Phoenix Nest Inc. employee's phone or email?
The Phoenix Nest Inc. annual revenue was $8 million in 2024.
Srikanth Bvsc is the Scientific Director of Phoenix Nest Inc..
4 people are employed at Phoenix Nest Inc..
Phoenix Nest Inc. is based in Brooklyn, New York.
The NAICS codes for Phoenix Nest Inc. are [32, 325, 3254].
The SIC codes for Phoenix Nest Inc. are [28, 80, 283].